The UltraMind Solution (142 page)

6
. Silverman, D. H., et al. 2001. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.
JAMA
286 (17):2120–127.

7
. Timonen, M. et al. 2007. Insulin resistance and depressive symptoms in young adult males: Findings from Finnish military conscripts.
Psychosom Med
69 (8):723–28.

8
. Hyman, M. A. 2006. Systems biology: The gut-brain-fat cell connection and obesity.
Altern Ther Health Med
12 (1):10–16. Review.

9
. Abbott, R. D., et al. 2004. Walking and dementia in physically capable elderly men.
JAMA
292 (12):1447–453.

10
. Camaris, G., et al. 2000. The Colorado Thyroid Disease Prevalence Study.
Arch Intern Med
160:526–34.

11
. Chueire, V. B., J. H., Romaldini and L. S. Ward. 2007. Subclinical hypothyroidism increases the risk for depression in the elderly.
Arch Gerontol Geriatr
44 (1):21–28. Epub 2006 May 5.

12
. Montero-Pedrazuela, A. et al. 2006. Modulation of adult hippocampal neurogenesis by thyroid hormones: implications in depressive-like behavior.
Mol Psychiatry
11 (4):361–71.

13
. Thomsen, A. F., et al. 2005. Increased risk of developing affective disorder in patients with hypothyroidism: a register-based study.
Thyroid
15 (7):700–7.

14
. Bauer, M., A. Heinz, and P. C. Whybrow. 2002. Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain.
Mol Psychiatry
7 (2):140–56. Review.

15
. Van Boxtel, M. P., et al. 2004. Thyroid function, depressed mood, and cognitive performance
in older individuals: the Maastricht Aging Study.
Psychoneuroendocrinology
29 (7):891–98.

16
. Miller, K. J., et al. 2006. Memory improvement with treatment of hypothyroidism.
Int J Neurosci
116 (8):895–906.

17
. Rack, S. K., and E. H. Makela. 2000. Hypothyroidism and depression: a therapeutic challenge.
Ann Pharmacother
34 (10):1142–1145.

18
. Bunevicius, R., et al. 1999. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism.
N Engl J Med
340 (6):424–29.

19
. Abraham, G., R. Miley, and J. Lawson. 2006. T3 augmentation of SSRI resistant depression.
J Affect Disord
91 (2–3):211–15. Epub 2006 February 17.

20
. Cooper-Kazaz, R., et al. 2007. Combined treatment with sertraline and liothyro-nine in major depression: A randomized, double-blind, placebo-controlled trial.
Arch Gen Psychiatry
64 (6):679–88.

21
. Porterfield, S. P. 1994. Vulnerability of the developing brain to thyroid abnormalities: environmental insults to the thyroid system.
Environ Health Perspect
102 Suppl 2:125–30. Review.

22
. Otake, T., et al. 2007. Thyroid hormone status of newborns in relation to utero exposure to PCBs and hydroxylated PCB metabolites.
Environ Res
105 (2):240–46. Epub 2007 May 8.

23
. Galletti, P. M., and G. Joyet. 1958. Effect of fluorine on thyroidal iodine metabolism in hyperthyroidism.
J Clin Endocrinol Metab
18 (10): 1102–1110.

24
. Rasheed, P., and L. S. Al-Sowielem. 2003. Prevalence and predictors of premenstrual syndrome among college-aged women in Saudi Arabia.
Ann Saudi Med
23 (6):381–87.

25
. Tan, R. S., and S. J. Pu. 2001. The andropause and memory loss: is there a link between androgen decline and dementia in the aging male?
Asian J Androl
3 (3): 169–74. Review.

26
. Rich-Edwards, J. W., et al. 2007. Milk consumption and the prepubertal somatotropic axis.
Nutr J
6:28.

27
. Milk, hormones and human health, 10/23–25/2006, Boston.
J Mammary Gland Biol Neoplasia
(2007) 12 (4):315.

28
. Pape-Zambito, D. A., A. L. Magliaro, and R. S. Kensinger, 2007. Concentrations of 17beta-estradiol in Holstein whole milk. J Diary Sci. 90 (7):3308–3313.

29
. Osterlund, M. K., M. R. Witt, and J. A. Gustafsson. 2005. Estrogen action in mood and neurodegenerative disorders: estrogenic compounds with selective properties— the next generation of therapeutics.
Endocrine
28 (3):235–42. Review.

30
. Pluchino, N., et al. 2001. Progesterone and progestins: effects on brain, allopregnanolone and beta-endorphin.
J Steroid Biochem Mol Biol
102 (1–5):205–13. Epub 2006 October 18. Review.

31
. Schulman, M. M., et al. 2007. The burden of testosterone deficiency syndrome in adult men: economic and quality-of-life impact.
J Sex Med
4 (4 Pt 1):1056–1069. Links.

32
. Bernhardt, P. C., et al. 1998. Testosterone changes during vicarious experiences of winning and losing among fans at sporting events.
Physiol Behav
65 (1):59–62.

33
. Sternbach, H. 1998. Age-associated testosterone decline in men: clinical issues for psychiatry.
Am J Psychiatry
155 (10):1310–1318. Review.

34
. Beauchet, O. 2001. Testosterone and cognitive function: current clinical evidence of a relationship.
Eur J Endocrinol
155 (6):773–81. Review.

35
. Wu, C.Y., T. J. Yu, and M. J. Chen. 2000. Age-related testosterone level changes and male andropause syndrome.
Chang Gung Med J
23 (6):348–53.

36
. Goldstat, R., et al. 2003. Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women.
Menopause
10 (5):390–98.

37
. Srinivasan, V., et al. 2006. Melatonin in mood disorders.
World J Biol Psychiatry
7 (3):138–51. Review.

38
. Blackman, M. R., et al. 2007. Growth hormone and sex steroid administration in healthy aged women and men: a randomized-controlled trial.
JAMA
288 (18):2282–2292.

39
. Van Cauter, E., R. Leproult, and L. Plat. 2000. Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men.
JAMA
284 (7):861–68.

40
. Harrington, J. M. 1994. Shift work and health—a critical review of the literature on working hours.
Ann Acad Med
23 (5):699–705. Review.

41
. Scott, J. P., L. R. McNaughton, and R. C. Polman. 2006. Effects of sleep deprivation and exercise on cognitive, motor performance and mood.
Physiol Behav
87 (2):396–408. Epub 2006 January 3.

42
. Young, T., J. Skatrud, and P. E. Peppard. 2004. Risk factors for obstructive sleep apnea in adults.
JAMA
291 (16):2013–2016. Review.

Chapter 8: Key #3: Cool Off Inflammation

1
. Elenkov, I. J., et al. 2005. Cytokine dysregulation, inflammation and well-being.
Neuroimmunomodulation
12 (5):255–69.

2
. Herbert, M. 2006. Autism: A brain disorder, or a disorder that affects the brain?
Clinical Neuropsychiatry
2 6:354–79.

3
. Ibid. 2005. Large brains in autism: The challenge of pervasive abnormality.
Neuroscientist
11 (5):417–40. Review.

4
. Vargas, D. L., et al. 2005. Neuroglial activation and neuroinflammation in the brain of patients with autism.
Ann Neurol
(2005) 57 (1):67–81. Erratum in
Ann Neurol
57 (2):304.

5
. Ashwood, P., J. Wills, J. Van de Water. 2006. The immune response in autism: a new frontier for autism research.
J Leukoc Biol
80 (1):1–15. Review.

6
. Das, U. N. 2007. Is depression a low-grade systemic inflammatory condition?
Am J Clin Nutr
85 (6):1665–666.

7
. Anisman, H., and Z. Merali. 2003. Cytokines, stress and depressive illness: brain-immune interactions.
Ann Med
35 (1):2–11. Review.

8
. Müller, N., and M. J. Schwarz. 2007. Immunological aspects of depressive disorders.
Nervenarzt
78 (11):1261–273.

9
. Bode, L., and H. Ludwig. 2003. Borna disease virus infection, a human mental-health risk.
Clin Microbiol Rev
16 (3):534–45. Review.

10
. Groves, D.A., and V. J. Brown. 2005. Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects.
Neurosci Biobehav
Rev 29 (3):493–500. Review.

11
. Parker, G., et al. 2006. Omega-3 fatty acids and mood disorders.
Am J Psychiatry
163 (6):969–78. Review.

12
. Blumenthal, J. A., et al. 2007. Exercise and pharmacotherapy in the treatment of major depressive disorder.
Psychosom Med
69 (7):587–96. Epub 2007 September 10.

13
. Papakostas, G. I., et al. 2005. Brain MRI white matter hyperintensities and one-carbon cycle metabolism in nongeriatric outpatients with major depressive disorder (Part II).
Psychiatry Res
140 (3):301–7. Epub 2005 November 16.

14
. Hoekstra, P. J., and R. B. Minderaa. 2005. Tic disorders and obsessive-compulsive disorder: Is autoimmunity involved?
Int Rev Psychiatry
17 (6):497–502. Review.

15
. Griffin, W. S. 2006. Inflammation and neurodegenerative diseases.
Am J Clin Nutr
83 (2):470S–74S. Review.

16
. McIntyre, R. S., et al. 2007. Should depressive syndromes be reclassified as “metabolic syndrome type II”?
Ann Clin Psychiatry
19 (4):257–64.

17
. Ibid. 2006. Managing psychiatric disorders with antidiabetic agents: Translational research and treatment opportunities.
Expert Opin Pharmacother
7 (10):1305–1321.

18
. Hunter, J. O. 1991. Food allergy—or enterometabolic disorder?
Lancet
338 (8765):495–96.

19
. King, D. S. 1981. Can allergic exposure provoke psychological symptoms? A double-blind test.
Biol Psychiatry
16 (1):3–19.

20
. Ludvigsson, J. F., et al. 2007. Coeliac disease and risk of mood disorders—a general population-based cohort study.
J Affect Disord
99 (1–3):117–26. Epub 2006 October 6.

21
. Ludvigsson, J. F., et al. 2007. Coeliac disease and risk of schizophrenia and other psychosis: A general population cohort study.
Scand J Gastroenterol
42 (2):179–85.

22
. Margutti, P., F. Delunardo, and E. Ortona. 2006. Autoantibodies associated with psychiatric disorders.
Curr Neurovasc Res
3 (2):149–57. Review.

23
. Hu, W. T., et al. 2006. Cognitive impairment and celiac disease.
Arch Neurol
63 (10):1440–1446.

24
. Wilders-Truschnig, M., et al. 2007. IgG antibodies against food antigens are correlated with inflammation and intima media thickness in obese juveniles.
Exp Clin Endocrinol Diabetes
116 (4):241–45.

25
. Liu, Y., T. Heiberg, and K. L. Reichelt. 2007. Towards a possible aetiology for depressions?
Behav Brain Funct
14 (3):47.

26
. MacDonald, T.T., and G. Monteleone. 2005. Immunity, inflammation, and allergy in the gut.
Science
307:1920–1925.

27
. Atkinson, W., et al. 2007. Food elimination based on IgG antibodies in irritable bowel syndrome: A randomised controlled trial.
Gut
53 (10):1459–1464.

Chapter 9: Key #4: Fix Your Digestion

1
.
www.digestive.niddk.nih.gov/statistics/statistics.htm

2
. Benarroch, E. E. 2007. Enteric nervous system: Functional organization and neurologic implications.
Neurology
13 69(20):1953–957. Review.

3
. Sandler, R. H., et al. 2000. Relief of psychiatric symptoms in a patient with Crohn’s disease after metronidazole therapy.
Clin Infect Dis
30 (1):213–14.

4
. Lin, H. 2004. Small intestinal bacterial overgrowth: A framework for understanding irritable bowel syndrome
JAMA
292:852–58.

5
. Orr, W. C., S. Elsenbruch and M. J. Harnish. 2000. Autonomic regulation of cardiac function during sleep in patients with irritable bowel syndrome.
Am J Gastroenterol
95:2865–2871.